Supernus Pharmaceuticals (SUPN) Q1 2023 Earnings

28FebConfirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
0.03
0.25
0.48
0.7

Details

Expected EPS
0.7
Actual EPS
0.43
Surprise EPS
-0.27
Surprise Percent
+38.57%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.43 per share for Q1 2023.

0 Comments

Share your thoughts